This Article Abstract Full Text (PDF) All Versions of this Article: 35/8/1925    most recent 01.STR.0000133129.58126.67v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coull, A. J. Articles by Rothwell, P. M. Search for Related Content PubMed PubMed Citation Articles by Coull, A. J. Articles by Rothwell, P. M. Related Collections Acute Cerebral Infarction

(Stroke. 2004;35:1925.)
© 2004 American Heart Association, Inc.

Original Contributions

Underestimation of the Early Risk of Recurrent Stroke

Evidence of the Need for a Standard Definition

From the Oxford Vascular (OXVASC) Study, Stroke Prevention Research Unit, Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK.

Correspondence to Dr Peter M. Rothwell, Stroke Prevention Research Unit, Department of Clinical Neurology, Radcliffe Infirmary, Woodstock Road, Oxford, OX2 6HE, UK. E-mail peter.rothwell{at}clneuro.ox.ac.uk

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background— There is considerable variation in the definitions used for recurrent stroke. Most epidemiological studies exclude events within the first 28 days (eg, Monitoring Trends and Determinants in Cardiovascular Disease [MONICA]) or events within 21 days in the same territory as the presenting event (eg, most stroke incidence studies). However, recurrence is most common during this early period and these restrictive definitions could underestimate the benefits of early prevention.

Methods— We determined the 90-day risk of recurrence after incident ischemic stroke in 2 population-based cohorts (Oxford Vascular Study [OXVASC] and Oxfordshire Community Stroke Project [OCSP]) with the 3 most common definitions: any stroke 24 hours after the incident event excluding early deterioration not caused by a stroke (definition A); as above, but excluding any stroke within 21 days in the same territory as the incident event (definition B); and any stroke 28 days after the incident event (definition C).

Results— 657 patients had 93 recurrent strokes between 24 hours and 90 days after the incident event. The 90-day recurrence risks (95% CI) using definition A were 14.5% (11.5 to 17.5) in the OCSP and 18.3% (10.8 to 25.8) in the OXVASC. The equivalent risks using definitions B and C were 8.3% (5.9 to 10.8) and 4.8% (2.8 to 6.7), respectively, in the OCSP and 7.0% (1.6 to 12.4) and 5.9% (1.0 to 10.9) in the OXVASC. The definition A risk of recurrence was particularly high after partial anterior (22.9%,17.5 to 28.2) and posterior (19.5%,13.0 to 25.9) circulation strokes.

Conclusions— The 3 most widely used definitions of recurrent stroke yield markedly different 90-day risks. We suggest that, where possible, definition A be adopted as the standard to avoid underestimation of risk and to allow valid comparison of different studies.

Key Words: epidemiology • ischemia • recurrence • stroke, ischemic

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Approximately 30% of strokes in population-based studies are recurrent events, and these recurrent strokes are more likely to be disabling or fatal than first strokes. Prevention of recurrent stroke is therefore of considerable importance to both individual and public health. Reliable data are required on the absolute risk of recurrent stroke so that stroke prevention services can be organized appropriately and the likely cost-effectiveness of preventive treatments can be assessed. A standard definition of recurrent stroke is also required so that different studies can be compared or meta-analyzed appropriately, time trends in risk can be determined accurately, and absolute risk reductions with treatment can be properly compared across trials.

The risk of stroke in the 3 months after a transient ischemic attack (TIA) is as much as 15% to 20% in population-based studies,^1,2 whereas the equivalent risk after a first-ever ischemic stroke is usually reported as 2% to 6%.^3–5 However, the majority of studies reporting these low risks excluded any potential recurrences that occurred within 21 days^6,7 or 28 days^8,9 after the incident stroke. The 28-day definition used in the Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) study⁸ and other influential population-based studies⁹ exclude all strokes within 28 days of the incident event, whereas other studies exclude only those events in the same vascular territory as the original event.^10,11 The same distinction is made in studies that use the 21-day definition, either excluding all strokes within 21 days^6,7 or only those strokes in the same vascular territory as the original stroke.^3,12,13 However, the distinction is relatively unimportant because most early recurrences are in the same territory as the initial stroke, particularly in patients with large artery atherosclerosis in whom the risk of early recurrence is highest.¹⁴ In contrast, other studies have used definitions that included all events occurring >24 hours after stroke, requiring only 24 hours of neurological stability before any recurrence,^14–16 and some appear to have also included new episodes occurring in a different vascular territory within 24 hours of the index stroke: either a new focal neurological deficit "occurring at any time after the index stroke,"¹² or an event that is "clearly in another part of the brain after the preceding stroke."^3,11,17 Finally, some studies have given no definition and relied on the clinical judgment of collaborating physicians¹⁸ or have not specified any time restriction.¹⁹

Given the importance of accurate determination of the risk of recurrent stroke, the potential for confusion because of the widespread use of very different definitions, and the possibility that some definitions underestimate the risk, we determined the effect of the most widely used definitions on the measured early risk of recurrent stroke in 2 high-quality population-based stroke incidence studies. Population-based data are important to minimize selection bias.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
The methods of the Oxfordshire Community Stroke Project (OCSP) and the Oxford Vascular Study (OXVASC) are similar and have been described in detail elsewhere.^20,21 Both studies aimed to determine the incidence, risk factors, and outcome of first-ever stroke in a prospective population-based study fulfilling the standard methodological criteria.²² In OCSP (1981 to 1986), all patients in a population of 105 000 registered with 50 family physicians (FPs) in 10 practices in both urban and rural settings. The OXVASC population covered 90 542 patients registered with 63 FPs from 9 practices, all of which had taken part in the OCSP. Each study developed multiple, comprehensive, overlapping search strategies to ensure as complete ascertainment as possible and collaborated very closely with FPs, who were encouraged to report all patients with a suspected acute cerebrovascular event during the study periods. Collaborating practices provided an accurate age–sex register with accurate and up-to-date estimates of the denominator, allowing easy identification of cross-boundary flow and turnover within the population.

In both studies, patients were assessed as soon as possible after the acute event by a study physician in a study clinic, in a hospital, or in the community. If a patient died before being seen, we attempted to obtain an eyewitness account and reviewed information with the FP and in hospital or ambulance service notes. In addition to a detailed clinical assessment and routine blood tests, patients in both studies had CT brain imaging and all incident strokes were subtyped as ischemic or hemorrhagic and according to the Bamford classification.²³

In both studies, the date and time of onset of first stroke and the date and time of any acute neurological deterioration in the acute phase or suspected stroke during follow-up were recorded. All hospitalized patients were reviewed if any neurological deterioration was suspected. After discharge, or for patients who were not admitted to hospital, follow-up was of 2 kinds. First, patients presenting to medical attention with a recurrent stroke would be reascertained by the same multiple overlapping search strategies as for incident strokes. Second, all patients were also reviewed face-to-face by a research nurse at 1, 6, and 12 months after the incident stroke. A study physician reassessed any patient in whom a recurrent vascular event was suspected and investigations, including brain imaging, were repeated.

A potential recurrent stroke was defined as any new acute neurological event with symptoms lasting >24 hours occurring after the initial ictus of the incident stroke (ie, definite acute worsening of an established nonprogressive deficit) that was not attributable to edema, brain shift, hemorrhagic transformation, intercurrent illness, hypoxia, or drug toxicity. Sudden worsening was required for consideration as a potential recurrent event, and gradual progression of an acute deficit was excluded. Recurrences were assessed in the same way as incident strokes, seen as rapidly as possible, and had urgent brain imaging. Strokes occurring in patients who had a definite TIA (ie, they returned entirely to normal within 24 hours), but had a subsequent stroke within 24 hours of onset of the TIA, were also excluded.

Analysis
Based on the above criteria for a potential recurrent stroke, we applied the 3 most widely used definitions of what constituted a recurrent stroke, defined as follows:

Definition A. Any recurrent stroke occurring >24 hours after the onset of the incident stroke, irrespective of vascular territory.^14–16

Definition B. Any recurrent stroke occurring >24 hours after the onset of the incident stroke in a different vascular territory and any recurrent stroke occurring in the same territory >21 days after the incident stroke.^3,12,13 Territories were defined as left carotid, right carotid, and posterior circulation. Note that previous users of this definition have varied in their interpretation. Most^3,12,13 stated that any recurrence within 21 days should be "clearly in another part of the brain (eg, contralateral hemisphere)." Others classified all acute events occurring within 21 days as part of the same event.^6,7 In none of these reports is it clear whether strokes that occurred in other vascular territories within 24 hours of the incident stroke were included.

Definition C. Any recurrent stroke occurring >28 days after the incident stroke.^8,9 Survival free of recurrent stroke was calculated from the time of onset of incident stroke by Kaplan–Meier analysis. Survival curves were produced for the definitions outlined above. The risk of recurrent stroke at 3 months was also determined for the different clinical subtypes.

	Results

Top Abstract Introduction Methods Results Discussion References

 
The OXVASC enrolled 128 first-ever strokes, of whom 123 (96%) had brain imaging or postmortem. The OCSP registered 675 first-ever strokes, of whom 542 (80%) had brain imaging or postmortem. Thirteen OXVASC patients and 104 OCSP patients presented with primary intracerebral hemorrhage (PICH) or subarachnoid hemorrhage (SAH) and were excluded. A further 29 (5%) OCSP patients were excluded because of inadequate documentation of the course of the acute phase after the incident stroke. A total of 657 patients (OXVASC, 115; OCSP, 542) with a first-ever ischemic stroke were therefore studied. The mean (SD) age and proportion of females were aged 75 years (11.6) and 54% (n=62), respectively, in the OXVASC, and aged 73.2 years (12.8) and 50% (n=272), respectively, in the OCSP. The vascular territories of incident strokes were carotid territory in 498 patients (75.8%: OXVASC, 91; OCSP, 407) and posterior circulation in 150 patients (22.8%: OXVASC, 24; OCSP, 126). Vascular territory was uncertain in 9 (1.4%) OCSP patients. The Bamford classification of incident strokes was as follows: 154 (23.4%: OXVASC, 28; OCSP, 126) lacunar infarcts (LACI); 230 (35.1%: OXVASC, 49; OCSP, 181) partial anterior circulation infarcts (PACI); 152 (23.1%: OXVASC, 25; OCSP, 127) posterior circulation infarcts (POCI); and 121 (18.4%: OXVASC, 13; OCSP, 108) total anterior circulation infarcts (TACI).

The risks of recurrent stroke at 3 months based on the 3 different definitions were highly consistent across the 2 studies (Table). If recurrence was confined to strokes occurring >28 days after the incident stroke (definition C), the 3-month risk was 4.8% (95% CI, 2.8 to 6.7) in the OCSP and 5.9% (1.0 to 10.9) in the OXVASC. The corresponding risks using the 21-day exclusion (definition B) were 8.3% (5.9 to 10.8) and 7.0% (1.6 to 12.4), respectively. In contrast, if only events within the first 24 hours after initial ictus were excluded (definition A), the risks increased to 14.5% (11.5 to 17.5) and 18.3% (10.8 to 25.8), respectively. Figure 1 shows the Kaplan–Meier curves for survival free of stroke for each of the definitions of recurrence.

View larger version (12K): [in this window] [in a new window]   Figure 1. Kaplan–Meier curves for survival free of stroke after a first-ever ischemic stroke in the OXVASC and OCSP for each of the definitions of recurrence.

Figure 2 shows the 3-month risk of recurrent stroke according to the clinical subtype. There was no statistically significant heterogeneity in risks between the OXVASC and OCSP for any subtype, and the data from the 2 studies were therefore pooled. The difference in prognosis between the different subtypes was qualitatively similar with each definition, but was most clear cut for definition A. Patients presenting with a PACI and POCI were at highest risk of an early recurrence with each of the different definitions, with the 3-month risk ranging from 8.1% (0.7 to 16.2) and 6.6% (2.2 to 11.0), respectively, for definition C to 22.9% (17.5 to 28.2) and 19.5% (13.0 to 25.9), respectively, for definition A. TACIs and LACIs had the lowest risk of early recurrence. These differences in risk were nonsignificant with definition C (P=0.07), moderately significant with definition B (P=0.01), but highly significant statistically with definition A (P<0.0001).

View larger version (27K): [in this window] [in a new window]   Figure 2. The 3-month risk of recurrent stroke according to Bamford clinical subtype23 in the OXVASC and OCSP combined.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
Analysis of data from 2 population-based studies with well-defined inclusion criteria and detailed follow-up has demonstrated that the definition used for recurrent stroke has a major effect on the measured risk of stroke risk at 3 months. The use of these different definitions partly explains the differences in risks of recurrent stroke that have been reported after a first-ever ischemic stroke (eg, 1-year risks of 7%,⁷ 10%,¹⁰ 12%,^3,12 and 15%¹⁵). We believe that the 24-hour exclusion definition of recurrence (definition A) is most clinically valid. The use of data from previous epidemiological studies that have used the more restrictive definitions in health economic and other effectiveness analyses will underestimate the potential benefits of early preventive treatment.

A standard definition of recurrent stroke is also required so that different studies can be compared or meta-analyzed appropriately, time trends in risk can be determined accurately, and absolute risk reductions with treatment can be properly compared across trials. Our data suggest that comparisons are likely to be highly biased unless definitions of recurrence are the same. If information on the early clinical course of patients is insufficiently detailed to use definition A reliably in certain types of large-scale epidemiological studies, for example, and more restrictive definitions are therefore necessary, it is important that researchers be aware of the potential underestimation of risk.

It is, of course, important that progression of the initial stroke, hemorrhagic transformation of infarction, systemic disturbances, or edema and mass effect resulting in fluctuations in cerebral perfusion are not misclassified as recurrent strokes.^24,25 For this reason, it has been argued that neurological deterioration occurring 24 hours after the incident event should only be included as a potential recurrent stroke if the neurological deficit was clearly different from the index stroke or was of a different clinical subtype,¹⁷ or if it occurred after an unequivocal period of neurological stability for 24 hours.^14–16 These stipulations are reasonable, although it should be noted that early recurrence is most common after minor ischemic stroke in which hemorrhagic transformation, edema and mass effect, and systemic disturbances are least likely.

It is also important to note that the use of the different definitions also leads to biases in analyses of the relationships between risk of recurrence and subtype of stroke. For clinical subtype, there was no significant difference in risk of recurrence when definition C was used, but there was highly significant heterogeneity with definition A, with higher risks in patients with PACI and POCI strokes. This difference is caused by recurrent events that tend to occur early in these subtypes of stroke. Patients with PACI have the highest prevalence of carotid stenosis, which has been shown to be associated with a high early risk of stroke,^11,14–16 and a high proportion of POCI strokes are thought to be caused by large artery atherosclerosis.²⁶ Indeed, published studies show that the risk of recurrent stroke following a posterior circulation TIA or minor stroke is significantly higher than the risk in patients with carotid territory events in studies with follow-up that commenced at the time of the event, but the risk is significantly lower in studies in which patients were recruited after the acute phase.²⁷

Our study has a number of potential shortcomings. First, we relied on the accuracy of the clinical recording of recurrent events. However, we were conservative in our definition of possible recurrent stroke by only including sudden acute neurological deterioration if there was considered to be a low probability that it was caused by edema, brain swelling, drugs, or other potential complications of stroke, or if there was definite evidence of recurrent stroke on brain imaging. The low early risk of recurrent stroke in patients with TACI syndromes suggests that we were not misdiagnosing nonspecific neurological deterioration as stroke. Moreover, the similar stroke recurrence risks measured in the OCSP and OXVASC suggested that interobserver agreement was likely to be good. If anything, we may have underestimated the early risk of recurrent events, particularly minor strokes, because patients were not reviewed between hospital discharge and 1 month, unless they sought medical attention with a further event. Second, we excluded sudden acute neurological deterioration that occurred within 24 hours of the onset of the initial stroke. Such early events have not previously been regarded as recurrent strokes, partly because the initial event cannot strictly be called a stroke based on current definitions before 24 hours have elapsed.²⁸ However, early deteriorations do occur in >10% of patients randomized in acute stroke trials, in the absence of signs of raised intracranial pressure or hemorrhagic transformation,²⁹ and are often associated with new ischemic lesions on brain imaging.³⁰ Sudden deterioration within 24 hours in patients who had not recovered from their initial event may therefore represent potentially preventable recurrent ischemic episodes. Interestingly, in the National Institute of Neurological Disorders and Stroke rt-tPA Stroke Trial placebo arm, patients not on aspirin at the time of their stroke were more likely to have early clinical deterioration.³¹ Further research, including studies of the interobserver agreement in the diagnosis of recurrence, is required.

In conclusion, we have shown that the risk of recurrence after first-ever ischemic stroke varies several-fold depending on the definition used. We have also shown that 2 of the definitions most widely used in epidemiological studies substantially underestimate the risk, particularly in patients with PACI and POCI syndromes. A standard definition of recurrent stroke is required so that different studies can be compared or meta-analyzed appropriately, time trends in risk can be determined accurately, and absolute risk reductions with treatment can be properly compared across trials. Comparisons are likely to be biased unless definitions of recurrence are the same.

	Acknowledgments

 
The Oxford Vascular Study was supported by grants from the Medical Research Council and the Stroke Association. We would like to thank all the collaborating general practices that we have acknowledged in previous work.² Dr Coull is funded by the Stroke Association. Dr Rothwell is funded by the Medical Research Council. Both the Stroke Association and the Medical Research Council fund the Oxford Vascular Study.

Received February 25, 2004; revision received April 6, 2004; accepted April 20, 2004.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Lovett JK, Dennis MS, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM. Very early risk of stroke after a transient ischemic attack. Stroke. 2003; 34: e138–e140.[CrossRef][Medline] [Order article via Infotrieve]

2. Coull AJ, Lovett JK, Rothwell PM; Oxford Vascular Study. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004; 328: 326–328.[Abstract/Free Full Text]

3. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long term risk of recurrent stroke after a first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1994; 25: 333–337.[Abstract]

4. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998; 50: 208–216.[Abstract/Free Full Text]

5. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke: the Framingham Study. Stroke. 1982; 13: 290–295.[Abstract/Free Full Text]

6. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, Katalinic A, Lang E, Gassmann KG, von Stockert TR. A prospective community-based study of stroke in Germany–the Erlangen Stroke Project (ESPro). Incidence and case fatality at 1, 3, and 12 months. Stroke. 1998; 29: 2501–2506.[Abstract/Free Full Text]

7. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov V, Strasser T. Cerebrovascular disease in the community: results of the WHO Collaborative Study. Bull World Health Organ. 1980; 58: 113–130.[Medline] [Order article via Infotrieve]

8. Sarti C, Stegmayr B, Tolonen H, Mahonen M, Tuomulehto J, Asplund K; for the WHO MONICA Project. Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project. Stroke. 2003; 34: 1833–1841.[Abstract/Free Full Text]

9. Bonita R, Anderson CS, Broad JB, Jamrozik KD, Stewart-Wynne EG, Anderson NE. Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based stroke registers. Stroke. 1994; 25: 552–557.[Abstract]

10. Thrift AG, Dewey HD, Macdonell RAL, McNeil JJ, Donnan GA. Stroke incidence on the East Coast of Australia. The North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2000; 31: 2087–2092.[Abstract/Free Full Text]

11. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke. 1989; 20: 983–989.[Abstract/Free Full Text]

12. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke. 1998; 29: 2491–2500.[Abstract/Free Full Text]

13. McGovern R, Hajat C, Rudd A, Wolfe C. Aetiological subtypes of strokes: the relationship between the index stroke subtype and recurrence stroke subtype. Cerebrovasc Dis. 2003; 16 (suppl 4): 14.[Medline] [Order article via Infotrieve]

14. Lovett JK, Coull A, Rothwell PM, on behalf of the Oxford Vascular Study. Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention. Neurology. 2004; 62: 569–574.[Abstract/Free Full Text]

15. Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival and recurrence. Stroke. 2000; 31: 1062.[Abstract/Free Full Text]

16. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001; 32: 2735–2740.[Abstract/Free Full Text]

17. Moroney JT, Bagiella E, Paik MC, Sacco RL, Desmond DW. Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke. 1998; 29: 2118–2124.[Abstract/Free Full Text]

18. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001; 32: 2333–2337.[Abstract/Free Full Text]

19. Carolei A, Marini C, Di Napoli M, Di Gianfilippo G, Santalucia P, Baldassarre M, DeMatteis G, di Orio F. High stroke incidence in the prospective community-based L’Aquila Registry (1994–1998). First year’s results. Stroke. 1997; 28: 2500–2506.[Abstract/Free Full Text]

20. Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981–86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry. 1988; 51: 1373–1380.[Abstract/Free Full Text]

21. Coull AJ, Silver LE, Rothwell PM. Implications of rates of non-fatal acute cerebrovascular events versus acute coronary events for provision of acute clinical services: Oxford Vascular Study. Cerebrovasc Dis. 2003; 16 (suppl 4): 1–125.

22. Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet. 1987; 2: 1196–1200.[Medline] [Order article via Infotrieve]

23. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991; 337: 1521–1526.[CrossRef][Medline] [Order article via Infotrieve]

24. Toni D, Fiorelli M, Gentile M, Bastanello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C. Deteriorating neurological deficit secondary to acute ischaemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol. 1995; 52: 670–675.[Abstract/Free Full Text]

25. Alexondrov A, Felberg RA, Demchuk AM, Christou I, Burgin WS, Malkoff M, Wojner AW, Grotta JC. Deterioration following spontaneous improvement: sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke. 2000; 31: 915–919.[Abstract/Free Full Text]

26. Gorelick PB, Caplan LR, Hier DB, Patel D, Langenberg P, Pessin MS, Biller J, Kornack D. Racial differences in the distribution of posterior circulation occlusive disease. Stroke. 1985; 16: 785–790.[Abstract/Free Full Text]

27. Flossman E, Rothwell PM. Prognosis of verterobrobasilar transient ischaemic attack and minor ischaemic stroke. Brain. 2003; 126: 1940–1954.[Abstract/Free Full Text]

28. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG; TIA working group. Transient ischemic attack–proposal for a new definition. N Engl J Med. 2002; 347: 1713–1716.[Free Full Text]

29. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke. 2001; 32: 661–668.[Abstract/Free Full Text]

30. Kang DW, Latour LL, Chalela JA, Dambrosia J, Warach S. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol. 2003; 54: 66–74.[CrossRef][Medline] [Order article via Infotrieve]

31. Brott T, Lu M, Kothari R, Fagan S, Frankel M, Grotta J, Broderick J, Kwiatkowski T, Lewandowski C, Haley C, Marler J, Tilley B. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke. 1998; 29: 1504–1509.[Abstract/Free Full Text]

This article has been cited by other articles:

				J. M. Wardlaw, M. D. Stevenson, F. Chappell, P. M. Rothwell, J. Gillard, G. Young, S. M. Thomas, G. Roditi, and M. J. Gough Carotid Artery Imaging for Secondary Stroke Prevention: Both Imaging Modality and Rapid Access to Imaging Are Important Stroke, November 1, 2009; 40(11): 3511 - 3517. [Abstract] [Full Text] [PDF]

				M. J. Alberts, D. L. Bhatt, J.-L. Mas, E. M. Ohman, A. T. Hirsch, J. Rother, G. Salette, S. Goto, S. C. Smith Jr, C.-S. Liau, et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry Eur. Heart J., October 1, 2009; 30(19): 2318 - 2326. [Abstract] [Full Text] [PDF]

				K M Mohan, S L Crichton, A P Grieve, A G Rudd, C D A Wolfe, and P U Heuschmann Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register J. Neurol. Neurosurg. Psychiatry, September 1, 2009; 80(9): 1012 - 1018. [Abstract] [Full Text] [PDF]

				A. Ois, E. Cuadrado-Godia, A. Rodriguez-Campello, J. Jimenez-Conde, and J. Roquer High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis Stroke, August 1, 2009; 40(8): 2727 - 2731. [Abstract] [Full Text] [PDF]

				A. Chandratheva, Z. Mehta, O. C. Geraghty, L. Marquardt, P. M. Rothwell, and On behalf of the Oxford Vascular Study Population-based study of risk and predictors of stroke in the first few hours after a TIA Neurology, June 2, 2009; 72(22): 1941 - 1947. [Abstract] [Full Text] [PDF]

				J. Smout, A. Dyker, M. Cleanthis, G. Ford, P. Kesteven, and G. Stansby Platelet Function Following Acute Cerebral Ischemia Angiology, June 1, 2009; 60(3): 362 - 369. [Abstract] [PDF]

				D.-W. Kang, S.-H. Yoo, S. Chun, K.-Y. Kwon, S. U. Kwon, J.-Y. Koh, and J. S. Kim Inflammatory and Hemostatic Biomarkers Associated With Early Recurrent Ischemic Lesions in Acute Ischemic Stroke Stroke, May 1, 2009; 40(5): 1653 - 1658. [Abstract] [Full Text] [PDF]

				P. Talelli and R. J. Greenwood Review: Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 387 - 405. [Abstract] [PDF]

				S. B. Coutts, M. D. Hill, C. R. Campos, Y. B. Choi, S. Subramaniam, J. C. Kosior, A. M. Demchuk, and for the VISION study group Recurrent Events in Transient Ischemic Attack and Minor Stroke: What Events Are Happening and to Which Patients? Stroke, September 1, 2008; 39(9): 2461 - 2466. [Abstract] [Full Text] [PDF]

				A. Ois, M. Gomis, A. Rodriguez-Campello, E. Cuadrado-Godia, J. Jimenez-Conde, C. Pont-Sunyer, G. Cuccurella, and J. Roquer Factors Associated With a High Risk of Recurrence in Patients With Transient Ischemic Attack or Minor Stroke Stroke, June 1, 2008; 39(6): 1717 - 1721. [Abstract] [Full Text] [PDF]

				N. A. Nickman, J. Biskupiak, F. Creekmore, H. Shah, and D. I . Brixner Antiplatelet medication management in patients hospitalized with ischemic stroke Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2250 - 2256. [Abstract] [Full Text] [PDF]

				P. M Rothwell Transient ischaemic attacks: time to wake up Heart, August 1, 2007; 93(8): 893 - 894. [Abstract] [Full Text] [PDF]

				W.-J. Jiang, X.-T. Xu, M. Jin, B. Du, K.-H. Dong, and J.-P. Dai Apollo Stent for Symptomatic Atherosclerotic Intracranial Stenosis: Study Results AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 830 - 834. [Abstract] [Full Text] [PDF]

				W.-J. Jiang, B. Du, T. W. Leung, X.-T. Xu, M. Jin, and K.-H. Dong Symptomatic Intracranial Stenosis: Cerebrovascular Complications from Elective Stent Placement Radiology, April 1, 2007; 243(1): 188 - 197. [Abstract] [Full Text] [PDF]

				W. J. Jiang, X. T. Xu, B. Du, K. H. Dong, M. Jin, Q. H. Wang, and N. Ma Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis Neurology, February 6, 2007; 68(6): 420 - 426. [Abstract] [Full Text] [PDF]

				D.-W. Kang, S. U. Kwon, S.-H. Yoo, K.-Y. Kwon, C. G. Choi, S. J. Kim, J.-Y. Koh, and J. S. Kim Early Recurrent Ischemic Lesions on Diffusion-Weighted Imaging in Symptomatic Intracranial Atherosclerosis Arch Neurol, January 1, 2007; 64(1): 50 - 54. [Abstract] [Full Text] [PDF]

				R. Luengo-Fernandez, A. M. Gray, and P. M. Rothwell Population-Based Study of Determinants of Initial Secondary Care Costs of Acute Stroke in the United Kingdom Stroke, October 1, 2006; 37(10): 2579 - 2587. [Abstract] [Full Text] [PDF]

				P. H.A. Halkes, L. J. Kappelle, J. van Gijn, I. van Wijk, P. J. Koudstaal, and A. Algra Large Subcortical Infarcts: Clinical Features, Risk Factors, and Long-Term Prognosis Compared With Cortical and Small Deep Infarcts Stroke, July 1, 2006; 37(7): 1828 - 1832. [Abstract] [Full Text] [PDF]

				W. J. Jiang, T. Srivastava, F. Gao, B. Du, K. H. Dong, and X. T. Xu Perforator stroke after elective stenting of symptomatic intracranial stenosis Neurology, June 27, 2006; 66(12): 1868 - 1872. [Abstract] [Full Text] [PDF]

				S. Chaturvedi and J. S. Yadav The Role of Antiplatelet Therapy in Carotid Stenting for Ischemic Stroke Prevention Stroke, June 1, 2006; 37(6): 1572 - 1577. [Abstract] [Full Text] [PDF]

				C. Jackson and C. Sudlow Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction Brain, November 1, 2005; 128(11): 2507 - 2517. [Abstract] [Full Text] [PDF]

				D. G. Jamieson, A. Parekh, and M. D. Ezekowitz Review of Antiplatelet Therapy in Secondary Prevention of Cerebrovascular Events: A Need for Direct Comparisons Between Antiplatelet Agents Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2005; 10(3): 153 - 161. [Abstract] [PDF]

				H. Christensen and P. M. Rothwell Early Recurrent Stroke or Neurological Deterioration? * Response Stroke, February 1, 2005; 36(2): 231 - 232. [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 35/8/1925    most recent 01.STR.0000133129.58126.67v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coull, A. J. Articles by Rothwell, P. M. Search for Related Content PubMed PubMed Citation Articles by Coull, A. J. Articles by Rothwell, P. M. Related Collections Acute Cerebral Infarction